Unmutated RRAS2 emerges as a key oncogene in post-partum-associated triple negative breast cancer
August 2, 2024
Mol Cancer (Jul 2024)
Insulin-like growth factor I sensitization rejuvenates sleep patterns in old mice
May 26, 2022
GeroScience (May 2022)
A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors
March 17, 2022
Cell Rep. (Mar 2022)
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
February 5, 2022
Mol Cancer (Feb 2022)
Discovery of novel 2,3,5-trisubstituted pyridine analogs as potent inhibitors of IL-1β via modulation of the p38 MAPK signaling pathway
November 6, 2021
Eur J Med Chem (Nov 2021)
Reduced Insulin-Like Growth Factor-I Effects in the Basal Forebrain of Aging Mouse
September 3, 2021
Front Aging Neurosci. (Sept 2021)
Structure-Activity Studies of Novel di-substituted [1,2,5]oxadiazolo[3,4-b]pyrazine Analogs Targeting the A-loop Regulatory Site of p38 MAP Kinase
July 13, 2021
Curr Med Chem (Jul 2021)
RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
October 9, 2019
J Exp Med (Jul 2019)
Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer’s Disease Co-Morbidities
April 10, 2019
J Alzheimers Dis. (Apr 2019)
